Annual Accounts Receivable
$1.47 M
+$595.00 K+68.08%
December 31, 2024
Summary
- As of March 12, 2025, XENE annual accounts receivable is $1.47 million, with the most recent change of +$595.00 thousand (+68.08%) on December 31, 2024.
- During the last 3 years, XENE annual accounts receivable has fallen by -$1.30 million (-46.87%).
- XENE annual accounts receivable is now -46.87% below its all-time high of $2.77 million, reached on December 31, 2021.
Performance
XENE Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$1.47 M
+$531.00 K+56.61%
December 31, 2024
Summary
- As of March 12, 2025, XENE quarterly accounts receivable is $1.47 million, with the most recent change of +$531.00 thousand (+56.61%) on December 31, 2024.
- Over the past year, XENE quarterly accounts receivable has stayed the same.
- XENE quarterly accounts receivable is now -70.97% below its all-time high of $5.06 million, reached on March 31, 2021.
Performance
XENE Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
XENE Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +68.1% | 0.0% |
| 3 y3 years | -46.9% | -49.7% |
| 5 y5 years | +80.7% | -49.7% |
XENE Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.9% | +68.1% | -49.7% | +82.5% |
| 5 y | 5-year | -46.9% | +80.7% | -71.0% | +82.5% |
| alltime | all time | -46.9% | +872.9% | -71.0% | +1038.8% |
Xenon Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.47 M(+68.1%) | $1.47 M(+56.6%) |
| Sep 2024 | - | $938.00 K(+10.0%) |
| Jun 2024 | - | $853.00 K(+2.4%) |
| Mar 2024 | - | $833.00 K(-4.7%) |
| Dec 2023 | $874.00 K(-11.4%) | $874.00 K(+8.6%) |
| Sep 2023 | - | $805.00 K(-62.1%) |
| Jun 2023 | - | $2.12 M(-4.5%) |
| Mar 2023 | - | $2.22 M(+125.4%) |
| Dec 2022 | $986.00 K(-64.3%) | $986.00 K(-60.3%) |
| Sep 2022 | - | $2.48 M(-1.7%) |
| Jun 2022 | - | $2.52 M(-13.7%) |
| Mar 2022 | - | $2.92 M(+5.7%) |
| Dec 2021 | $2.77 M(+51.8%) | $2.77 M(-14.5%) |
| Sep 2021 | - | $3.23 M(+10.8%) |
| Jun 2021 | - | $2.92 M(-42.3%) |
| Mar 2021 | - | $5.06 M(+177.7%) |
| Dec 2020 | $1.82 M(+124.1%) | $1.82 M(+13.2%) |
| Sep 2020 | - | $1.61 M(-9.9%) |
| Jun 2020 | - | $1.79 M(+10.5%) |
| Mar 2020 | - | $1.62 M(+98.9%) |
| Dec 2019 | $813.00 K | $813.00 K(+289.0%) |
| Sep 2019 | - | $209.00 K(+22.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $171.00 K(+29.5%) |
| Mar 2019 | - | $132.00 K(-12.6%) |
| Dec 2018 | $151.00 K(-65.5%) | $151.00 K(-16.1%) |
| Sep 2018 | - | $180.00 K(+5.3%) |
| Jun 2018 | - | $171.00 K(-60.4%) |
| Mar 2018 | - | $432.00 K(-1.4%) |
| Dec 2017 | $438.00 K(+119.0%) | $438.00 K(+239.5%) |
| Sep 2017 | - | $129.00 K(-34.8%) |
| Jun 2017 | - | $198.00 K(+4.8%) |
| Mar 2017 | - | $189.00 K(-5.5%) |
| Dec 2016 | $200.00 K(-36.5%) | $200.00 K(-66.4%) |
| Sep 2016 | - | $595.00 K(-9.6%) |
| Jun 2016 | - | $658.00 K(+70.5%) |
| Mar 2016 | - | $386.00 K(+22.5%) |
| Dec 2015 | $315.00 K(+46.5%) | $315.00 K(+15.0%) |
| Sep 2015 | - | $274.00 K(+45.7%) |
| Jun 2015 | - | $188.00 K(-84.4%) |
| Mar 2015 | - | $1.21 M(+460.5%) |
| Dec 2014 | $215.00 K(-51.1%) | $215.00 K(+32.7%) |
| Sep 2014 | - | $162.00 K(-55.5%) |
| Jun 2014 | - | $364.00 K(-17.3%) |
| Dec 2013 | $440.00 K(+12.2%) | $440.00 K |
| Dec 2012 | $392.00 K | - |
FAQ
- What is Xenon Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual accounts receivable year-on-year change?
- What is Xenon Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Xenon Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of XENE is $1.47 M
What is the all time high annual accounts receivable for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual accounts receivable is $2.77 M
What is Xenon Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, XENE annual accounts receivable has changed by +$595.00 K (+68.08%)
What is Xenon Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of XENE is $1.47 M
What is the all time high quarterly accounts receivable for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly accounts receivable is $5.06 M
What is Xenon Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, XENE quarterly accounts receivable has changed by $0.00 (0.00%)